Risk of Ischemic Stroke in Patients with Covid-19 versus Patients with Influenza
Importance: Case series without control groups suggest that Covid-19 may cause ischemic stroke, but whether Covid-19 is associated with a higher risk of ischemic stroke than would be expected from a viral respiratory infection is uncertain. Objective: To compare the rate of ischemic stroke between patients with Covid-19 and patients with influenza, a respiratory viral illness previously linked to stroke. Design: A retrospective cohort study. Setting: Two academic hospitals in New York City. Participants: We included adult patients with emergency department visits or hospitalizations with Covid-19 from March 4, 2020 through May 2, 2020. Our comparison cohort included adult patients with emergency department visits or hospitalizations with influenza A or B from January 1, 2016 through May 31, 2018 (calendar years spanning moderate and severe influenza seasons). Exposures: Covid-19 infection confirmed by evidence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the nasopharynx by polymerase chain reaction, and laboratory-confirmed influenza A or B. Main Outcomes and Measures: A panel of neurologists adjudicated the primary outcome of acute ischemic stroke and its clinical characteristics, etiological mechanisms, and outcomes. We used logistic regression to compare the proportion of Covid-19 patients with ischemic stroke versus the proportion among patients with influenza. Results: Among 2,132 patients with emergency department visits or hospitalizations with Covid-19, 31 patients (1.5%; 95% confidence interval [CI], 1.0%-2.1%) had an acute ischemic stroke. The median age of patients with stroke was 69 years (interquartile range, 66-78) and 58% were men. Stroke was the reason for hospital presentation in 8 (26%) cases. For our comparison cohort, we identified 1,516 patients with influenza, of whom 0.2% (95% CI, 0.0-0.6%) had an acute ischemic stroke. After adjustment for age, sex, and race, the likelihood of stroke was significantly higher with Covid-19 than with influenza infection (odds ratio, 7.5; 95% CI, 2.3-24.9). Conclusions and Relevance: Approximately 1.5% of patients with emergency department visits or hospitalizations with Covid-19 experienced ischemic stroke, a rate 7.5-fold higher than in patients with influenza. Future studies should investigate the thrombotic mechanisms in Covid-19 in order to determine optimal strategies to prevent disabling complications like ischemic stroke..
| Medienart: |
|
|---|
Preprint| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
bioRxiv.org - (2021) vom: 24. März Zur Gesamtaufnahme - year:2021 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Merkler, Alexander E. [VerfasserIn] |
|---|
| Links: |
|---|
| doi: |
10.1101/2020.05.18.20105494 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
XBI017925118 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | XBI017925118 | ||
| 003 | DE-627 | ||
| 005 | 20230429080749.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200525s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1101/2020.05.18.20105494 |2 doi | |
| 035 | |a (DE-627)XBI017925118 | ||
| 035 | |a (DE-599)biorXiv10.1101/2020.05.18.20105494 | ||
| 035 | |a (biorXiv)10.1101/2020.05.18.20105494 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 570 |q DE-84 | |
| 100 | 1 | |a Merkler, Alexander E. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Risk of Ischemic Stroke in Patients with Covid-19 versus Patients with Influenza |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Importance: Case series without control groups suggest that Covid-19 may cause ischemic stroke, but whether Covid-19 is associated with a higher risk of ischemic stroke than would be expected from a viral respiratory infection is uncertain. Objective: To compare the rate of ischemic stroke between patients with Covid-19 and patients with influenza, a respiratory viral illness previously linked to stroke. Design: A retrospective cohort study. Setting: Two academic hospitals in New York City. Participants: We included adult patients with emergency department visits or hospitalizations with Covid-19 from March 4, 2020 through May 2, 2020. Our comparison cohort included adult patients with emergency department visits or hospitalizations with influenza A or B from January 1, 2016 through May 31, 2018 (calendar years spanning moderate and severe influenza seasons). Exposures: Covid-19 infection confirmed by evidence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the nasopharynx by polymerase chain reaction, and laboratory-confirmed influenza A or B. Main Outcomes and Measures: A panel of neurologists adjudicated the primary outcome of acute ischemic stroke and its clinical characteristics, etiological mechanisms, and outcomes. We used logistic regression to compare the proportion of Covid-19 patients with ischemic stroke versus the proportion among patients with influenza. Results: Among 2,132 patients with emergency department visits or hospitalizations with Covid-19, 31 patients (1.5%; 95% confidence interval [CI], 1.0%-2.1%) had an acute ischemic stroke. The median age of patients with stroke was 69 years (interquartile range, 66-78) and 58% were men. Stroke was the reason for hospital presentation in 8 (26%) cases. For our comparison cohort, we identified 1,516 patients with influenza, of whom 0.2% (95% CI, 0.0-0.6%) had an acute ischemic stroke. After adjustment for age, sex, and race, the likelihood of stroke was significantly higher with Covid-19 than with influenza infection (odds ratio, 7.5; 95% CI, 2.3-24.9). Conclusions and Relevance: Approximately 1.5% of patients with emergency department visits or hospitalizations with Covid-19 experienced ischemic stroke, a rate 7.5-fold higher than in patients with influenza. Future studies should investigate the thrombotic mechanisms in Covid-19 in order to determine optimal strategies to prevent disabling complications like ischemic stroke. | ||
| 700 | 1 | |a Parikh, Neal S. |e verfasserin |4 aut | |
| 700 | 1 | |a Mir, Saad |e verfasserin |4 aut | |
| 700 | 1 | |a Gupta, Ajay |e verfasserin |4 aut | |
| 700 | 1 | |a Kamel, Hooman |e verfasserin |4 aut | |
| 700 | 1 | |a Lin, Eaton |e verfasserin |4 aut | |
| 700 | 1 | |a Lantos, Joshua |e verfasserin |4 aut | |
| 700 | 1 | |a Schenck, Edward J. |e verfasserin |4 aut | |
| 700 | 1 | |a Goyal, Parag |e verfasserin |4 aut | |
| 700 | 1 | |a Bruce, Samuel S. |e verfasserin |4 aut | |
| 700 | 1 | |a Kahan, Joshua |e verfasserin |4 aut | |
| 700 | 1 | |a Lansdale, Kelsey N. |e verfasserin |4 aut | |
| 700 | 1 | |a LeMoss, Natalie M. |e verfasserin |4 aut | |
| 700 | 1 | |a Murthy, Santosh B. |e verfasserin |4 aut | |
| 700 | 1 | |a Stieg, Philip E. |e verfasserin |4 aut | |
| 700 | 1 | |a Fink, Matthew E. |e verfasserin |4 aut | |
| 700 | 1 | |a Iadecola, Costantino |e verfasserin |4 aut | |
| 700 | 1 | |a Segal, Alan Z. |e verfasserin |4 aut | |
| 700 | 1 | |a Campion, Thomas R. |e verfasserin |4 aut | |
| 700 | 1 | |a Diaz, Ivan |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Cenai |e verfasserin |4 aut | |
| 700 | 1 | |a Navi, Babak B. |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t bioRxiv.org |g (2021) vom: 24. März |
| 773 | 1 | 8 | |g year:2021 |g day:24 |g month:03 |
| 856 | 4 | 0 | |u https://doi.org/10.1001/jamaneurol.2020.2730 |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1101/2020.05.18.20105494 |z kostenfrei |3 Volltext |
| 912 | |a GBV_XBI | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |j 2021 |b 24 |c 03 | ||
| 953 | |2 045F |a 570 | ||